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Abstract  
Tibetans have adapted to the chronic hypoxia of high altitude and display a distinctive suite of 
physiologic adaptations, including augmented hypoxic ventilatory response and resistance to 
pulmonary hypertension.  Genome-wide studies have consistently identified compelling genetic 
signatures of natural selection in two genes of the Hypoxia Inducible Factor pathway, PHD2 and 
HIF2A.  The product of the former induces the degradation of the product of the latter.  Key 
issues regarding Tibetan PHD2 are whether it is a gain of function or loss of function allele, and 
how it might contribute to high-altitude adaptation.  Tibetan PHD2 possesses two amino acid 
changes, D4E and C127S.  We previously showed that in vitro, Tibetan PHD2 is defective in its 
interaction with p23, a cochaperone of the HSP90 pathway, and we proposed that Tibetan 
PHD2 is a loss of function allele.  Here, we report that additional PHD2 mutations at or near 
Asp-4 or Cys-127 impair interaction with p23 in vitro.  We find that mice with the Tibetan Phd2 
allele display augmented hypoxic ventilatory response, supporting this loss of function proposal.  
This is phenocopied by mice with a mutation in p23 that abrogates the PHD2:p23 interaction.  
Hif2a haploinsufficiency, but not the Tibetan Phd2 allele, ameliorates hypoxia-induced increases 
in right ventricular systolic pressure.  The Tibetan Phd2 allele is not associated with hemoglobin 
levels in mice.  We propose that Tibetans possess genetic alterations that both activate and 
inhibit selective outputs of the HIF pathway to facilitate successful adaptation to the chronic 
hypoxia of high altitude. 
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Significance  
Tibetans have lived for thousands of years at an altitude where oxygen concentrations are low 
(hypoxia).  They are known to have physiologic adaptations, including increased breathing 
responses to low oxygen and decreased blood pressure in the lungs.  Tibetans also are known 
to have mutations in two genes, PHD2 and HIF2A, that are central components of a molecular 
hypoxia response pathway.  We provide evidence here that Tibetan PHD2 promotes increased 
breathing responses to hypoxia.  The Tibetan HIF2A gene is likely to account for the decreased 
blood pressure in the lungs.  Therefore, the hypoxia response pathway has been altered in 
Tibetans to facilitate adaptation to the hypoxia of high altitude. 
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Introduction 
The Tibetan plateau has an average altitude of about 4,300 m (14,000 feet), an elevation at 
which the partial pressure of oxygen is only 60% of that at sea level.  Yet Tibetans have 
occupied this plateau for at least 30,000 years, with some estimates as high as 40,000 years (1, 
2).  Studies have revealed a number of notable physiologic changes in the Tibetan population.  
In comparison to Andeans, another high-altitude adapted population, Tibetans display 
augmented hypoxic ventilatory response (HVR), resistance to pulmonary hypertension, and 
relatively low hemoglobin (Hb) levels (3, 4).  These are considered to be adaptive.  For example, 
the resistance to pulmonary hypertension lessens the risk of right heart failure, while the 
relatively low Hb levels (which approach that of lowlanders) may decrease the risk of thrombotic 
events associated with blood hyperviscosity.  The augmented HVR can facilitate the intake of 
oxygen into the lungs. 
 Genome-wide studies have identified evidence of natural selection in Tibetans.  The two 
genes that have consistently ranked the highest in these studies are the PHD2 (also known as 
EGLN1) and HIF2A (also known as EPAS1) genes (4-7).  The encoded proteins, Prolyl 
Hydroxylase Domain protein 2 (PHD2) and Hypoxia Inducible Factor-2 (HIF-2), respectively, 
play central roles in the Hypoxia Inducible Factor (HIF) pathway, which in turn mediates the 
central transcriptional response to hypoxia in metazoans (8-10).  In this pathway, PHD2-
catalyzed, oxygen dependent, prolyl hydroxylation of HIF- (of which HIF-1 and HIF-2 are the 
major paralogues) allows recognition by the von Hippel Lindau tumor suppressor protein, a 
component of an E3 ubiquitin ligase complex that targets HIF- for degradation (Fig. 1A, left).  
Under hypoxia, this posttranslational modification is arrested, leading to the stabilization of HIF-
, its heterodimerization with Aryl Hydrocarbon Receptor Nuclear Translocator, and the 
activation of HIF target genes that promote adaptive responses to hypoxia (Fig.1A, right).  HIF-
1 and HIF-2 have overlapping and distinct gene targets (11).  For example, HIF-1 is the 
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principal paralogue that upregulates glycolysis while HIF-2 is the main paralogue that activates 
the ERYTHROPOIETIN (EPO) gene, which allows oxygen-dependent regulation of red cell 
mass. 
 The Tibetan HIF2A allele arose through introgression from Denisovans, an archaic 
hominin species (12).  The Tibetan HIF2A allele does not encode for amino acid changes in the 
HIF-2 protein.  Rather, the SNPs under strongest selection, which number over 30, all reside 
within non-coding regions of the gene.  In contrast, the Tibetan PHD2 allele is not a result of 
introgression from Denisovans (13).  Moreover, there are two SNPs, rs186996510 and 
rs12097901, in the PHD2 gene which are tightly linked and enriched in Tibetans that encode for 
D4E and C127S amino acid substitutions, respectively (14, 15).  Hence, the Tibetan PHD2 allele 
encodes for a D4E/C127S double amino acid substitution.  A central question regarding this 
allele is whether it is a gain of function or loss of function allele.  Some studies support a model 
in which Tibetan PHD2 is a gain of function allele that derives from increased affinity for oxygen 
leading to enhanced hydroxylase activity towards HIF- (15).   
 Other studies support a very different model.  The affected amino acids flank a highly 
conserved MYND-type zinc finger at the N-terminus of PHD2 (Fig. 1B).  The zinc finger binds to 
a Pro-Xaa-Leu-Glu (PXLE) motif found in p23 and FK506 Binding Protein 38 (FKBP38), two 
cochaperones of the HSP90 pathway (16).  The principal function of the HSP90 pathway is to 
promote proper folding of client proteins (Fig. 1C).  First, cochaperones that include select 
FKBPs such as FKBP38, FKBP51, and FKBP52, recruit partially folded client proteins to HSP90 
(17, 18).  These FKBPs employ a tetratricopeptide repeat domain to bind a Met-Glu-Glu-Val-Asp 
motif at the C-terminus of HSP90.  ATP and p23 then bind.  p23 binds to the N-terminal domain 
of HSP90 and inhibits ATP hydrolysis, allowing client protein maturation.  Following ATP 
hydrolysis, the folded client protein and ADP are released.  HIF- is a client protein of HSP90 
(19, 20).  The PHD2:PXLE interaction therefore recruits PHD2 to a pathway that folds HIF-, 
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and this interaction thereby facilitates HIF- hydroxylation (Fig. 1D) (21).  The D4E/C127S 
double amino acid substitution markedly impairs the interaction of PHD2 with p23 and, to a 
much lesser extent, FKBP38 (22).  Importantly, this effect is not seen with either the D4E or the 
C127S substitution alone (22).  Hence, the behavior of the D4E/C127S double amino acid 
substitution is very different from that of single amino acid substitutions.  These studies 
therefore suggest that the Tibetan PHD2 allele is a hypomorphic loss of function allele that 
impairs PHD2-induced hydroxylation of HIF- (22).   
 Here, we further characterize the Tibetan PHD2 allele.  We find that in vitro, additional 
PHD2 mutations at or in the vicinity of the Tibetan mutations impair interaction with p23.  We 
generated a knockin mouse line with Tibetan Phd2 to allow examination of respiratory 
parameters such as minute ventilation, respiratory frequency, tidal volume, and HVR, which can 
be measured by whole body plethysmography of mice.  Tibetan Phd2 mice display augmented 
HVR, supporting a model in which PHD2 is a hypomorphic loss of function allele.  Hif2a 
haploinsufficiency in the mouse, which we have used to model the Tibetan HIF2A haplotype, 
protects against hypoxia-induced increases in right ventricular systolic pressure (RVSP) in the 
absence or presence of the Tibetan Phd2 allele.  We propose that the HIF pathway has been 
reconfigured in Tibetans to allow select adaptive phenotypes to emerge that promote successful 
adaption to hypoxia. 
 
Results  
Mutations in the vicinity of Asp-4 and Cys-127 of PHD2 impair interaction with p23 in 
vitro.  The Tibetan D4E/C127S mutation in PHD2 decreases its interaction with p23 (22).  We 
examined additional residues in the vicinity of Asp-4 and Cys-127 using coimmunoprecipitation 
assays.  We first prepared mutations at or in the vicinity of Asp-4, an amino acid that is highly 
conserved across mammalian species (Fig. 1B).  We find that, similar to the single D4E 
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substitution (22), N3A, N3S, D4A, D4N, and S5A substitutions all preserve the PHD2:p23 
interaction (Fig. 1E).  We took one of these substitutions, D4N, and combined it with the Tibetan 
C127S substitution, and we find that this combination (D4N/C127S) impairs binding (Fig. 1E, 
lane 22, top panel).  Therefore, it behaves similarly to the Tibetan D4E/C127S double amino 
acid substitution (Fig. 1E, lane 4, top panel).  We next examined mutations at or in the vicinity of 
Cys-127.  Of note, Cys-127 is substituted for by serine in PHD2 orthologues from primates such 
as baboon and gorilla, and is not present at all in PHD2 orthologues from other species, such as 
mice or hamster (Fig. 1B).  Similar to the C127S substitution (22), the S125A, P126A, and 
R128A substitutions all preserve the interaction (Fig. 1F).  However, C127A, C127V, and C127P 
substitutions markedly diminish it (Fig. 1F, lanes 18, 20, and 24, top panel).  It might be noted 
that amino acid 131 in bovine PHD2 (corresponding to amino acid 127 in human PHD2) is a 
proline (Fig. 1B).  Whether the presence of Pro-131 in bovine PHD2 has an effect on its binding 
to p23 remains to be determined, since bovine PHD2 differs from human PHD2 at nearly 60 
additional residues in the linker region between the zinc finger and the catalytic domain.   
 These in vitro studies show that in addition to the Tibetan D4E/C127S mutation, selective 
single or double amino acid mutations at the sites of the Tibetan substitutions also have the 
capacity to disrupt interaction with p23.  We also examined whether the detrimental effect of the 
PHD2 D4E/C127S substitution on p23 binding depends on the exact spacing between residues 
4 and 127 of PHD2.  We generated two constructs bearing internal deletions of PHD2 that 
change the spacing by either 16 or 14 amino acids (76-91 and 97-110), respectively (Fig. 
1G).  Wild type versions maintain the interaction, but D4E/C127S versions abolish it (Fig. 1H).  
Together with the previous data, these results indicate that the PHD2:p23 interaction is 
unexpectedly sensitive to amino acid changes outside of the zinc finger itself.  Furthermore, in 
all situations in which there was a change, it was a loss of function (i.e., decreased interaction). 
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 Prior to generating a mouse model for Tibetan PHD2, we performed 
coimmunoprecipitation studies and confirmed that both human and mouse PHD2 can bind to 
p23, with the former binding somewhat more tightly than the latter (Fig. S1A, lanes 3 and 5, top 
panel).  We inspected the amino acid sequences of the human and mouse PHD2 zinc fingers 
(residues 21-58), and noted that all are identical with the exception of amino acid 34, which is 
serine in human, glycine in mouse (Fig. S1B).  A different protein, the transcriptional 
corepressor ETO, contains a MYND-type zinc finger homologous to that of PHD2, and mutation 
of the corresponding serine residue in ETO (Ser-675) to alanine weakens its interaction with its 
peptide ligand SMRT (1101-1113) (23).  This suggests that the difference in affinity of human 
versus mouse PHD2 might be due at least in part to the amino acid residue at position 34.  
Indeed, mutation of Ser-34 in human PHD2 to Gly weakens the interaction (Fig. S1C, lanes 3 
and 5, top panel), and conversely, mutation of Gly-34 in mouse Phd2 to Ser strengthens the 
interaction (Fig. S1D, lanes 3 and 5, top panel). Thus, there are some modest differences in 
affinity of human and mouse PHD2 for p23 due in part to amino acid 34.  More important, 
however, is the observation that both bind p23. 
 
The Tibetan Phd2 allele is associated in augmented HVR in mice.  Both Asp-4 and Cys-127, 
the residues affected by the Tibetan allele, reside within exon 1 of the PHD2 gene, but only the 
former is conserved between human and mouse (Fig. 1B).  We therefore replaced the coding 
sequence of murine Phd2 exon 1 with that of wild type human or Tibetan PHD2 exon 1 using 
homologous recombination in embryonic stem cells (Fig. 2A).  The predicted chimeric protein is 
99% identical at the amino acid level to the human protein, therefore effectively humanizing the 
murine Phd2 gene (Fig. 2A and Fig. S2).  Pilot transfection studies using murine Hepa1-6 (Fig. 
2B) or N2a (Fig. S3) cells revealed that the D4E/C127S substitution in the predicted chimeric 
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PHD2 (hmPHD2) protein abolishes interaction with p23, showing that the defective binding is 
recapitulated in both a chimeric PHD2 protein context and in a murine cellular environment.   
We proceeded to generate a mouse line with the Tibetan PHD2 exon 1 substitution 
(Phd2 Tib) (Fig. S4A).  Sequencing confirmed the presence of the D4E and C127S substitutions 
(Fig. 2C).  We have previously generated the corresponding control mouse line in which the 
coding sequence of murine Phd2 exon 1 is replaced by that of wild type human PHD2 exon 1 
(hereafter referred to as Phd2 WT) (24).  There was no difference in litter sizes between the two 
genotypes [5.19  1.38 (SD) for Phd2 WT/WT x Phd2 WT/WT crosses, vs. 5.00  1.93 (SD) for Phd2 
Tib/Tib x Phd2 Tib/Tib crosses; n = 16 litters for each; P = 0.75].  Protein expression of Phd2 WT and 
Phd2 Tib were comparable in heart, lung, liver, kidney, brainstem, and brain cortex (Fig. S5).  We 
generated mouse embryonic fibroblasts from these mice and we immunoprecipitated 
endogenous Phd2 from these cells, confirming defective binding of Tibetan Phd2 to endogenous 
p23 (Fig. 2D, lanes 3 and 6). 
 We employed whole body plethysmography to measure ventilation under normoxia and 
after acute exposure to 12% O2.  Representative plethysmography traces are shown in Fig. S6.  
In these experiments, we included a low concentration (3%) of CO2 under both normoxic and 
hypoxic conditions in order to blunt the fall in PCO2 caused by hypoxic hyperventilation, resulting 
in a more sustained HVR (25, 26).  In control experiments, the Phd2 WT/WT and Phd2 Tib/Tib mice 
did not display any differences in ventilatory responses to hypercapnia alone (5% CO2; Fig. S7).  
In comparing Phd2 Tib/Tib with Phd2 WT/WT mice (Fig. 3A) under normoxia, we did not observe any 
differences in baseline minute ventilation (Fig. 3B).  We did, however, observe an increased 
HVR in the Phd2 Tib/Tib as compared to Phd2 WT/WT mice (Fig. 3C).  There was an increased 
hypoxia-induced change in tidal volume, but not respiratory frequency, in the Phd2 Tib/Tib as 
compared to Phd2 WT/WT mice (Fig. 3D and Fig. 3E, respectively).   
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 Chronic exposure to hypoxia can potentiate HVR, which has been termed ventilatory 
acclimatization to hypoxia (27).  We exposed Phd2 WT/WT and Phd2 Tib/Tib mice to seven days of 
hypoxia (12% O2) and then measured HVR.  We observe that following this chronic hypoxia 
exposure, Phd2 Tib/Tib mice display increased HVR as compared to Phd2 WT/WT mice (Fig. S8).  
The Phd2 WT/WT and Phd2 Tib/Tib mice were maintained in C57BL/6 background.  The C57BL/6J 
mouse strain is prone to exhibiting spontaneous respiratory pauses (28).  We found no 
differences in the frequency of spontaneous pauses between Phd2 Tib/Tib with Phd2 WT/WT mice 
under either normoxic or hypoxic conditions (Fig. S9). 
The zinc finger of PHD2 shows a defective interaction with p23 as well as a more modest 
decrease in binding to FKBP38 (22). Therefore, we sought to determine whether this respiratory 
phenotype could be recapitulated by reciprocal mutations in either partner protein (Fig. 4A).  In 
vitro, PXLE > PXAA mutations in either p23 (L159A/E160A) or FKBP38 (L55A/E56A) abolish 
their interaction with PHD2 (Fig. 4B and Fig. 4C, respectively). We employed Crispr technology 
to knock in these mutations into the murine p23 (also known as Ptges3) and Fkbp38 (also 
known as Fkbp8) loci (Fig. 4D).  We denote these alleles as p23 AA and Fkbp38 AA, respectively.  
As with the Phd2 WT/WT and Phd2 Tib/Tib mice, the Fkbp38 AA/AA mice were generated in a 
C57BL/6 background.  The p23 AA/AA mice were generated in a mixed BL6/129 background 
because of difficulty generating them in a C57BL/6 background. Plethysmography studies 
showed that the PXLE > PXAA mutations have no effect on baseline minute ventilation in either 
mouse line (Fig. S10A and Fig. S10B).  In addition, no differences were seen in HVR between 
Fkbp38 AA/AA and Fkbp38 +/+ mice (Fig. S10C).  In contrast, we did observe increased HVR with 
p23 AA/AA mice as compared to p23 +/+ mice (Fig. 4E), as was previously observed in the Phd2 
Tib/Tib mice (Fig. 3C).  It should be noted that we cannot rule out the possibility that the mixed 
background of the p23 AA/AA and control p23 +/+ mice might influence the magnitude of this 
difference in HVR. 
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To extend these studies, we considered the possibility that the Tibetan respiratory 
phenotype would be maintained in a Fkbp38 AA/AA background, given that the Tibetan mutation 
appears to predominantly affect interaction with p23.  We therefore crossed the Fkbp38 AA/AA 
mouse with Phd2 WT/WT and Phd2 Tib/Tib mice, and generated Phd2 WT/WT; Fkbp38 AA/AA and Phd2 
Tib/Tib; Fkbp38 AA/AA mice in a C57BL/6 background.  We did not observe differences in baseline 
minute ventilation under normoxia (Fig. S11).  However, there was an increased HVR in the 
Phd2 Tib/Tib; Fkbp38 AA/AA as compared to Phd2 WT/WT; Fkbp38 AA/AA mice (Fig. 4F).  It will be of 
interest in the future to compare Phd2 WT/WT; p23 AA/AA and Phd2 Tib/Tib; p23 AA/AA mice. 
Previous studies examining Phd2 loss of function due to either point mutations in or 
genetic deletion of the Phd2 gene have consistently shown that Phd2 loss of function is 
associated with increases in either HVR or hypoxia-induced tidal volume, respiratory frequency, 
or minute ventilation, or a combination of these (21, 26, 29).  These findings therefore support 
the notion that the Tibetan Phd2 allele is a loss of function allele, consistent with the biochemical 
studies demonstrating impaired interaction of Tibetan PHD2 with p23. 
 
The Tibetan Phd2 allele is not associated with either Hb or RVSP in mice.  We examined 
whether the Tibetan Phd2 allele might be associated with changes in Hb levels.  We exposed 
Phd2 WT/WT and Phd2 Tib/Tib mice to three weeks of hypoxia (12% O2) and then measured Hb and 
Hct.  As shown in Fig. 5A and Fig. S12, respectively, we do not observe any differences in 
either.  In this experiment, we also examined whether there might be an interaction between 
Phd2 and Hif2a alleles.   While the Tibetan HIF2A allele does not involve any coding sequence 
substitutions, and the causative SNP(s) has yet to be defined, the following lines of evidence 
suggest that Tibetan HIF2A allele may be a hypomorphic loss of function allele.  (1) The Tibetan 
HIF2A allele is strongly correlated with low Hb concentration (30-33). (2) HIF2A mRNA levels 
from peripheral blood mononuclear cells, umbilical endothelial cells, and placentas from 
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Tibetans are lower than those from control Han Chinese (32, 34).  (3) Tibetans who are 
homozygous for the Tibetan HIF2A allele have a blunted plasma EPO response to hypoxia in 
comparison to Tibetans who are homozygous for the lowland allele (34).  Accordingly, we 
employed mice with heterozygous deficiency of Hif2a (Hif2a +/-) to model this allele.  In the 
presence of heterozygous loss of Hif2a, we do not observe differences in Hb or Hct between 
Phd2 WT/WT and Phd2 Tib/Tib mice (Fig. 5A and Fig. S12, respectively).  Under normoxia, we 
similarly did not observe any differences in Hb or Hct levels between any of the four genotypes 
(Fig. S13A and Fig. S13B).  In addition, there were no differences in red blood cell (RBC), white 
blood cell (WBC), platelet (Plt) counts, serum EPO levels, or renal Vegfa (a Hif gene target) 
mRNA levels (Fig. S14).   
The lack of an effect of Hif2a haploinsufficiency on these parameters in this experiment is 
consistent with the lack of effect of Hif2a haploinsufficiency observed by others upon exposure 
to hypoxia (29, 35).  Importantly, however, others have observed that acute global deletion of 
Hif2a reverses hypoxia-induced erythrocytosis (29), consistent with a critical role for Hif-2 in 
boosting red cell mass under hypoxic conditions.  Evidence for a central role for HIF-2 in 
erythropoiesis is also provided by patients with protein stabilizing missense mutations in the 
HIF2A gene (36).  We crossed the Phd2 WT/WT and Phd2 Tib/Tib mice to mice with one such Hif2a 
gain of function mutation (Hif2a G536W/+) (37).  As expected, the Hif2a G536W/+ allele increases Hb 
or Hct in Phd2 WT/WT mice (Fig. S15).  However, no differences were observed in the Hb or Hct 
of Phd2 Tib/Tib; Hif2a G536W/+ as compared to Phd2 WT/WT; Hif2a G536W/+ mice.  Furthermore, no 
differences were seen between Phd2 Tib/Tib; Hif2a G536W/+ compared to Phd2 WT/WT; Hif2a G536W/+ 
mice in terms of WBC, Plt counts, or serum EPO (Fig. S16). 
 We exposed Phd2 WT/WT and Phd2 Tib/Tib mice with or without Hif2a haploinsufficiency to 
three weeks of hypoxia (12% O2) and measured RVSP.  We did not observe any significant 
difference in RVSP between the Phd2 WT/WT and Phd2 Tib/Tib mice  (Figure 5B).  Hif2a 
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haploinsufficiency decreased RVSP in Phd2 WT/WT mice (compare first and third columns), 
consistent with previous observations (32, 35).  It also decreased RVSP in Phd2 Tib/Tib mice 
(compare second and fourth columns). However, we did not observe differences between Phd2 
WT/WT; Hif2a +/- and Phd2 Tib/Tib; Hif2a +/- mice.  Under normoxic conditions, we did not observe 
any differences in RVSP between Phd2 WT/WT and Phd2 Tib/Tib mice, either in the absence or 
presence of Hif2a haploinsufficiency (Fig S17). 
 
Discussion 
We propose that the Tibetan PHD2 allele is a hypomorphic loss of function allele that leads to 
an augmented HVR, while the Tibetan HIF2A allele is a loss of function allele that provides 
protection against pulmonary hypertension and erythrocytosis (Fig. 5C).  Lowlanders have a 
robust HVR, but after long-term acclimatization to high altitude, their HVR declines (3, 27, 38). 
Tibetans have an augmented HVR that approaches the ancestral response of lowlanders (3, 38-
40), which may allow them to maintain high oxygen delivery from the lungs.  In contrast to 
Tibetans, Andeans exhibit a blunted HVR (41).  Thus, this study provides evidence that Tibetans 
possess a distinct combination of PHD2 and HIF2A alleles that reconfigures the HIF pathway in 
a manner that facilitates adaptation to the chronic hypoxia of high altitude.   
 The proposition that Tibetan PHD2 is hypomorphic might appear to be at odds with the 
observations that acute global knockout of Phd2 leads to erythrocytosis and conditional 
knockout of Phd2 in endothelial cells induces pulmonary hypertension (42-46). However, it must 
be emphasized that, in vitro, the Tibetan amino acid substitutions have a relatively selective 
detrimental effect on the interaction with the PXLE motif of p23 as opposed to the PXLE motif of 
other proteins such as FKBP38.  Moreover, the zinc finger of PHD2 facilitates, but is not 
essential, for PHD2-induced hydroxylation of HIF- (21).  Hence, the Tibetan allele is a 
hypomorphic as opposed to a complete loss of function allele, and one would therefore not 
 15 
expect it to behave in a similar manner to a complete loss of function.  Indeed, we have 
previously reported that a partial loss of function Phd2 P294R/+ mouse line does not exhibit 
pulmonary hypertension (47).  Furthermore, while patients with erythrocytosis-associated 
heterozygous HIF2A mutations are at risk for developing pulmonary hypertension (48), those 
with erythrocytosis-associated PHD2 mutations do not appear to be.  In addition, while some 
studies have shown an association of the Tibetan PHD2 allele with lower Hb levels (14, 49), 
other studies have not (50).  It may also be noted that in one study which specifically examined 
the D4E/C127S PHD2 haplotype, there was no association with Hb level in Tibetan highlanders 
(when examined irrespective of HIF2A haplotype) (51).  Finally, our experiments here 
demonstrate that the Tibetan Phd2 allele in genetically engineered mice neither augments nor 
inhibits the erythrocytosis and RVSP increase induced by hypoxia (Fig. 5A and Fig. 5B). 
We speculate that loss of PHD2 function in Tibetans is sufficient to cause an 
augmentation of HVR, but has not reached the threshold to produce changes in the hypoxia-
induced levels of either Hb level or RVSP.  Whether this is due to intrinsic threshold differences 
of these physiologic responses to changes in the PHD2:p23 interaction, tissue specific 
differences in the utilization of this interaction, or tissue specific differences in the utilization of 
other PXLE-containing proteins will require further investigation.  For example, p23 may be 
important for proper PHD2 function in the carotid body, while FKBP38 may be important for 
some other PHD2 function in some other tissue.  Alternatively, differential sensitivity of outputs 
to the degree of loss of function is also plausible, and indeed this idea is observed here in 
another context.  Heterozygous loss of Hif2a is sufficient to protect against hypoxia-induced 
increases in RVSP (Fig. 5B).  On the other hand, heterozygous loss of Hif2a is not sufficient to 
protect against hypoxia-induced erythrocytosis (Fig. 5A), at least in this experimental setting, as 
has been observed by others (29, 35).  However, as has been mentioned above, acute global 
deletion of Hif2a is protective (29). 
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There is evidence that the Tibetan HIF2A allele was present in the Tibetan gene pool at 
an earlier time than the Tibetan PHD2 allele (14).  Thus, it is possible that the early emergence 
of the Tibetan HIF2A allele, which presumably dampens the HIF pathway and produces the 
proposed beneficial effects on Hb levels and pulmonary artery pressure, may have facilitated 
the appearance of a loss of function Tibetan PHD2 allele which acts in the opposite direction on 
the HIF pathway and that otherwise might be unfavorable under certain circumstances.  This 
could then allow the PHD2-dependent contribution of a beneficial respiratory phenotype.  Such 
an epistatic relationship will require further investigation.  Interestingly, in high altitude adapted 
deer mice, intramolecular epistasis has been observed in Hb, allowing the emergence of Hb 
variants with high affinity for oxygen (52).  Alternatively, it is possible that the emergence of the 
Tibetan PHD2 allele might have served to ameliorate potentially detrimental effects of a 
preexisting Tibetan HIF2A allele, i.e., it may represent an example of genetic compensation 
(53).  A possible detrimental effect of a loss of function HIF2A allele is suppression of the 
hypoxic ventilatory response (29, 54).  In this regard, an issue that remains to be resolved is 
whether the Tibetan PHD2 allele-associated augmentation of HVR is HIF-1 or HIF-2 
dependent.  Evidence for the involvement of both HIF- paralogues in respiratory control has 
been presented (29, 37, 54-56). 
In summary, we propose that this particular configuration of the HIF pathway both 
activates and inhibits selective outputs of the pathway and provides the core framework for high-
altitude adaptation in Tibetans.  Tibetans are protected against chronic mountain sickness (also 
known as Monge’s Disease), which is characterized by erythrocytosis, hypoventilation, and 
pulmonary hypertension (57), and our model may provide a mechanistic explanation for this.  
Additional genes, which also display signals of selection, may further contribute to this 
phenotype (5, 13, 33). 
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Materials and Methods 
Mouse lines.  A mouse line with the Phd2 Tib  allele was generated by homologous 
recombination in ES cells followed by injection into blastocysts.  Mouse lines with the p23 AA and 
Fkbp38 AA alleles were generated by injection of Crispr reagents into fertilized oocytes.  Full 
details of this as well as other Materials and Methods are provided in the SI Appendix. 
Statistical analysis.  One way analysis of variance with Tukey’s post hoc test (GraphPad 
Prism) or unpaired Student’s t tests were employed for statistical analysis, as appropriate.  
Differences were considered significant when P < 0.05.  Unless otherwise specified, data are 
presented as mean  standard error of the mean (SEM). 
Data availability.  All data are included in the manuscript and SI Appendix. 
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Figure Legends 
 
Fig. 1.  Effect of mutations in vicinity of PHD2 Asp-4 and Cys-127 on the PHD2:p23 
interaction.  (A) The HIF pathway.  See text for details.  VHL, von Hippel Lindau protein.  For 
simplicity, Aryl Hydrocarbon Nuclear Receptor Translocator has been omitted.  (B) Diagram of 
PHD2, showing locations of zinc finger (ZF) domain, prolyl hydroxylase (PH) domain, Asp-4 
(diamond), and Cys-127 (triangle).  Sequence of residues 1-7 and 121-133 are shown at the 
bottom, with Asp-4 and Cys-127 are as indicated.  (C) The HSP90 pathway.  See text for 
details.  (D) Model for zinc finger-dependent recruitment of PHD2 to the HSP90 pathway to 
facilitate HIF- hydroxylation.  PLXE motifs in p23 and FKBP38 are shown, as are Asp-4 and 
Cys-127 in PHD2.  (E, F, and H) HEK293 FT cells were transfected with expression plasmids for 
the indicated proteins.  The cells were lysed and subjected to immunoprecipitation with anti-Flag 
antibodies, and then the immunoprecipitates and aliquots of lysate were examined by Western 
blotting as indicated.  In (H), the D4E and C127S substitutions refer to the native amino acid 
sequence.  (G) Diagram of internal deletion mutants of PHD2. 
 
Fig. 2.   Phd2 Tib gene targeting strategy.  (A) Numbers directly above exons denote exon 
number.  Italicized numbers either above or below exons indicate % identity of amino acid 
sequence encoded by exon with that of the corresponding Tibetan exon. (B) Hepa 1-6 cells 
were transfected with expression plasmids for the indicated proteins.  hmPHD2 denotes a 
chimeric protein consisting of human PHD2 (1-297) and mouse Phd2 (275-400).  The amino 
acid sequence of this humanized WT Phd2 is provided in Fig. S2.  The cells were lysed and 
subjected to immunoprecipitation with anti-Flag antibodies, and then the immunoprecipitates 
and aliquots of lysate were examined by Western blotting as indicated. (C) DNA sequencing 
chromatograms of tail DNA confirming D4E and C127S substitutions.  The sequence is from 3ʹ 
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to 5ʹ (reverse complement).  Amino acids 4 and 127 are as indicated. (D) Immortalized mouse 
embryonic fibroblasts with the indicated genotypes were lysed, incubated with either control 
mAb or anti-PHD2 mAb 6.9, and immunoprecipitations were performed with protein G-agarose.  
The immunoprecipitates and aliquots of the lysate were then examined by Western blotting with 
anti-p23 antibodies.  
  
Fig. 3.   Increased HVR in Tibetan Phd2 mice.  (A) Model for Tibetan PHD2.  Compared to 
wild type PHD2, Tibetan PHD2 has a defect in its interaction with p23.  Hence, Tibetan PHD2 
hydroxylates HIF- less efficiently than wild type PHD2 (as indicated by difference in thickness 
of the arrow from PHD2 to HIF-). (B) Minute ventilation under normoxia (21% O2/3% CO2) was 
compared between Phd2 WT/WT and Phd2 Tib/Tib mice.  (C-E) Mice were acutely exposed to 12% 
O2/3% CO2, and HVR (C), tidal volume change (D), and respiratory frequency change (E) were 
measured.  In (B-E), mice were 2-4 months of age, with n = 18-19 per group.  * P < 0.05.  P 
values were as follows:  (B) 0.246, (C) 0.020, (D) 0.018, (E) 0.493. 
 
Fig. 4.   Increased HVR in p23 AA/AA and Phd2 Tib/Tib;Fkbp38 AA/AA mice.  (A) The recruitment 
of PHD2 to HSP90 pathway (left) is impaired by PXLE > PXAA mutations in p23 or Fkbp38 
(right). (B and C) HEK293 FT cells were transfected with expression plasmids for the indicated 
proteins.  The cells were lysed and subjected to immunoprecipitation with anti-Flag antibodies, 
and then the immunoprecipitates and aliquots of lysate were examined by Western blotting as 
indicated.  (D) DNA sequencing chromatograms of tail DNA from p23 AA/AA and Fkbp38 AA/AA 
mice.  The sequences are from (left) 5ʹ to 3ʹ and (right) 3ʹ to 5ʹ.  Mutated amino acids are in bold.  
(E and F) Mice with the indicated genotypes were maintained in normoxia (21% O2/3% CO2) 
and then acutely exposed to 12% O2/3% CO2, and HVR were measured.  In (E), mice were 2-3 
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months of age, with n = 14 per group.  In (F), mice were 2-3 months of age, with n = 25-26 per 
group. * P < 0.05, ** P < 0.01.  P values were as follows:  (E) 0.007, (F) 0.030. 
 
Fig. 5.  Hypoxic Hb and RVSP responses in Tibetan Phd2 mice with or without Hif2a 
haploinsufficiency.  (A and B) Mice with indicated genotypes were exposed to three weeks of 
hypoxia (12% O2).  Hb (A) or RVSP (B) was then measured.  In (A), mice were 3-9 months of 
age, with n = 9-10 per group.   In (B), mice were 6-9 months of age, with n = 7-9 per group.  * P 
< 0.05, ns = non-significant (P > 0.05).  (C) Model for reconfiguration of the HIF pathway in 
Tibetans.  Low altitude inhibitants at low altitude (normoxia) have high PHD2 activity and low 
HIF-2 protein levels.  At high altitude (hypoxia), PHD2 activity decreases, resulting in high HIF-
2 protein levels.  Tibetans harbor a hypomorphic PHD2 allele that leads to augmented HVR.  
Tibetans also possess a hypomorphic HIF-2 allele that blunts selective aspects of the hypoxic 
response, including the right ventricular pressure and erythropoietic responses.  Sizes of PHD2 
and HIF-2 icons indicate their relative activity.  P values were as follows:  (A) Phd2 WT/WT vs. 
Phd2 Tib/Tib = 0.999.  Phd2 WT/WT; Hif2a +/- vs. Phd2 Tib/Tib; Hif2a +/- = 0.932. (B) Phd2 WT/WT vs. 
Phd2 Tib/Tib = 0.949.  Phd2 WT/WT; Hif2a +/- vs. Phd2 Tib/Tib; Hif2a +/- = 0.852.  Phd2 WT/WT vs. Phd2 
WT/WT; Hif2a +/- = 0.010.  Phd2 Tib/Tib vs. Phd2 Tib/Tib; Hif2a +/- = 0.005. 
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